Inspira Technologies appoints Benad Goldwasser as Chairman of the Board

Respiration medical technology company Inspira Technologies has appointed Professor Benad Goldwasser as Chairman of its Board of Directors to help steer the long-term development of the company’s medical device portfolio.

Professor goldwasser brings three decades of experience in founding, developing, and overseeing the exits of medical device companies. Following a career as a urologic surgeon, professor Goldwasser co-founded Viamed (sold to Medtronic), co-founded Medinol (which partnered with Boston Scientific), and co-founded venture capital firm Biomedical Investments, where he oversaw the sale of Colbar to Johnson & Johnson as Managing Director.

“I was immediately impressed by Inspira Technologies’ vision, which has the opportunity to gain a significant market share in the respiratory support device industry,” Goldwasser said. “Inspira’s solution extends respiratory treatment to patients who would otherwise be treated with mechanical ventilation or would not be treated at all due to lack of access to intensive care. As Chairman of the Board, I look forward to joining Inspira’s long-term journey and helping to change the way respiratory patients are treated.”

Dagi Ben-Noon, co-founder and CEO of Inspira Technologies, called Professor Goldwasser ‘a healthcare veteran with an unmatched history’, confirming that he “will work closely with company leadership to steward the development of our Augmented Respiration Technology (ART), our groundbreaking respiratory support solution.”

Inspira Technologies was founded in 2018 by Ben-Noon, Joe Hayon, and Udi Nussinovitch, who serve as CFO and CMO, respectively. The company has developed a respiratory support system that oxygenates blood and elevates and stabilizes oxygen levels in patients.